[Drug-induced hypoglycemia].
Rikitake
Takahiro
T
Department of Pharmacy, Osaka City General Hospital.
Kajitani
Fumihiro
F
Sato
Toshihiko
T
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000434:Alcoholic Beverages / Q000009:adverse effects; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D000962:Antimalarials / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced*; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007328:Insulin / Q000009:adverse effects; D007538:Isoniazid / Q000009:adverse effects; D011802:Quinidine / Q000009:adverse effects; D013453:Sulfonylurea Compounds / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D000962:Antimalarials; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; D011802:Quinidine; D001241:Aspirin; D007538:Isoniazid